China ready to take on the world

"Nowadays, Chinese pharmaceutical companies are capable of expanding their market worldwide, and Chinese medicine is capable of entering major Western markets, such as the U.S.," says Zhao Chao, president of Buchang Pharmaceuticals. "It's just a matter of how." Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.